High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis: immune surveillance and retinoid treatment
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
1986
|
| Schlagworte: | |
| Beschreibung: | Zsfassung in niederländ. Sprache. - Groningen, Rijksuniv., Diss. |
| Beschreibung: | 115 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV001061329 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 890315s1986 ad|| m||| 00||| eng d | ||
| 035 | |a (OCoLC)50994635 | ||
| 035 | |a (DE-599)BVBBV001061329 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Voorst Vader, Pieter C. van |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis |b immune surveillance and retinoid treatment |c door Pieter Cornelis van Voorst Vader |
| 264 | 1 | |c 1986 | |
| 300 | |a 115 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Zsfassung in niederländ. Sprache. - Groningen, Rijksuniv., Diss. | ||
| 650 | 7 | |a Farmacotherapie |2 gtt | |
| 650 | 7 | |a Huidtumoren |2 gtt | |
| 650 | 7 | |a Immuunreacties |2 gtt | |
| 650 | 7 | |a Tretinoine |2 gtt | |
| 650 | 7 | |a Vitamine A |2 gtt | |
| 650 | 0 | 7 | |a Risikofaktor |0 (DE-588)4050131-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hautkrebs |0 (DE-588)4140169-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Hautkrebs |0 (DE-588)4140169-4 |D s |
| 689 | 0 | 1 | |a Risikofaktor |0 (DE-588)4050131-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000642172 | ||
Datensatz im Suchindex
| _version_ | 1804115478468100096 |
|---|---|
| any_adam_object | |
| author | Voorst Vader, Pieter C. van |
| author_facet | Voorst Vader, Pieter C. van |
| author_role | aut |
| author_sort | Voorst Vader, Pieter C. van |
| author_variant | v p c v v vpcv vpcvv |
| building | Verbundindex |
| bvnumber | BV001061329 |
| ctrlnum | (OCoLC)50994635 (DE-599)BVBBV001061329 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01396nam a2200397 c 4500</leader><controlfield tag="001">BV001061329</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890315s1986 ad|| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50994635</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001061329</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Voorst Vader, Pieter C. van</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis</subfield><subfield code="b">immune surveillance and retinoid treatment</subfield><subfield code="c">door Pieter Cornelis van Voorst Vader</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1986</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">115 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Zsfassung in niederländ. Sprache. - Groningen, Rijksuniv., Diss.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmacotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Huidtumoren</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immuunreacties</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tretinoine</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vitamine A</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Risikofaktor</subfield><subfield code="0">(DE-588)4050131-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hautkrebs</subfield><subfield code="0">(DE-588)4140169-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hautkrebs</subfield><subfield code="0">(DE-588)4140169-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Risikofaktor</subfield><subfield code="0">(DE-588)4050131-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000642172</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV001061329 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:23:15Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000642172 |
| oclc_num | 50994635 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 115 S. Ill., graph. Darst. |
| publishDate | 1986 |
| publishDateSearch | 1986 |
| publishDateSort | 1986 |
| record_format | marc |
| spelling | Voorst Vader, Pieter C. van Verfasser aut High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment door Pieter Cornelis van Voorst Vader 1986 115 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Zsfassung in niederländ. Sprache. - Groningen, Rijksuniv., Diss. Farmacotherapie gtt Huidtumoren gtt Immuunreacties gtt Tretinoine gtt Vitamine A gtt Risikofaktor (DE-588)4050131-0 gnd rswk-swf Hautkrebs (DE-588)4140169-4 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Hautkrebs (DE-588)4140169-4 s Risikofaktor (DE-588)4050131-0 s DE-604 |
| spellingShingle | Voorst Vader, Pieter C. van High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment Farmacotherapie gtt Huidtumoren gtt Immuunreacties gtt Tretinoine gtt Vitamine A gtt Risikofaktor (DE-588)4050131-0 gnd Hautkrebs (DE-588)4140169-4 gnd |
| subject_GND | (DE-588)4050131-0 (DE-588)4140169-4 (DE-588)4113937-9 |
| title | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment |
| title_auth | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment |
| title_exact_search | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment |
| title_full | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment door Pieter Cornelis van Voorst Vader |
| title_fullStr | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment door Pieter Cornelis van Voorst Vader |
| title_full_unstemmed | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment door Pieter Cornelis van Voorst Vader |
| title_short | High risk groups in cutaneous oncology: basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis |
| title_sort | high risk groups in cutaneous oncology basal cell nevus syndrome xeroderma pigmentosum and epidermodysplasia verruciformis immune surveillance and retinoid treatment |
| title_sub | immune surveillance and retinoid treatment |
| topic | Farmacotherapie gtt Huidtumoren gtt Immuunreacties gtt Tretinoine gtt Vitamine A gtt Risikofaktor (DE-588)4050131-0 gnd Hautkrebs (DE-588)4140169-4 gnd |
| topic_facet | Farmacotherapie Huidtumoren Immuunreacties Tretinoine Vitamine A Risikofaktor Hautkrebs Hochschulschrift |
| work_keys_str_mv | AT voorstvaderpietercvan highriskgroupsincutaneousoncologybasalcellnevussyndromexerodermapigmentosumandepidermodysplasiaverruciformisimmunesurveillanceandretinoidtreatment |